SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000891020-00-001835
Filing Date
2000-10-25
Accepted
2000-10-25 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDUEL 13D v66532sc13d.txt SC 13D 27324
2 JOINT FILING AGREEMENT v66532ex1.txt EX-1 1886
3 AGREEMENT AND PLAN OF MERGER v66532ex2.txt EX-2 272529
4 VOTING AGREEMENT v66532ex3.txt EX-3 24474
  Complete submission text file 0000891020-00-001835.txt   328841
Mailing Address 600 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 600 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-553-2000
COULTER PHARMACEUTICALS INC (Subject) CIK: 0000942416 (see all company filings)

IRS No.: 943219075 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-52083 | Film No.: 745548
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1124 COLUMBIA STREET SUTIE200 SEATTLE WA 98104
Business Address 1124 COLUMBIA STREET SUIE 200 SEATTLE WA 98104 2066675711
CORIXA CORP (Filed by) CIK: 0001042561 (see all company filings)

IRS No.: 911654387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)